Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEP II enema plus mesalazine for mild to moderate active ulcerative colitis
ChiCTR1900025900Phase 3Not yet recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of DHEP II, Salcrozine and compound phellodendron liquid in autoimmune colitis (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Relapse interval. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
DHEP IISalcrozinecompound phellodendron liquid
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on ChiCTR1900025900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025900.